Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor

https://doi.org/10.1016/0006-291X(85)90614-XGet rights and content

Abstract

Peritoneal exudate cells were collected from thioglycollate stimulated mice, extracted an examined for the presence of immunoreactive and bioactive fibroblast growth factor (FGF). The crude extract stimulated in a dose dependent fashion the proliferation of vascular endothelial cells derived from the bovine aortic arch. The extract also showed a parallel and dose-dependent inhibition of binding in a highly specific radioimmunoassay for FGF. The immunoreactive FGF (ir-FGF) contained in the extract was retained on a heparin-sepharose affinity column as is characteristic of pituitary FGF. Reversephase HPLC of the macrophage-derived material reveals one biologically active form of FGF which coelutes with the major form of immunoreactivity. The results demonstrate the presence of FGF in these cells and suggest that at least one of the hitherto unidentified mitotic activities in these extracts is due to a mitogen indistinguishable from FGF.

References (18)

  • R.C. Page et al.

    Int. Rev. Cyt

    (1978)
  • D. Gospodarowicz et al.

    Exp. Eye Res

    (1979)
  • E.R. Unanue

    Am. J. Pathol

    (1976)
  • R. Takemura et al.

    Am. J. Physiol

    (1984)
  • B.M. Martin et al.

    J. of Immunology J. of Immunology

    (1981)
  • D. Gospodarowicz et al.
  • P. Bőhlen et al.
  • D. Gospodarowicz et al.
  • P.J. Polverini et al.

    Nature

    (1977)
There are more references available in the full text version of this article.

Cited by (323)

  • Fibrin-based delivery strategies for acute and chronic wound healing

    2018, Advanced Drug Delivery Reviews
    Citation Excerpt :

    Basic fibroblast growth factor (bFGF; FGF-2) [17,61], vascular endothelial growth factor 165 (VEGF165) [18], transforming growth factor-β1 (TGF-β1) [62], platelet-derived growth factor (PDGF) [63], insulin-like growth factor 1 (IGF-1) [63,64] and interleukin 1β (IL-1β) [65] can all be found within a natural fibrin clot. Moreover, circulating growth factors can be sequestered to fibrin via heparin [66,67] which has known affinity for epidermal growth factor (EGF) [68], bFGF [69], PDGF-A and -B [70,71] and VEGF165 [72]. The localized bioactivity and concerted actions of these growth factors in the clot drive neovascularization and subsequent remodeling of the wound bed, which is key to wound healing.

  • Fibrin matrices: The versatile therapeutic delivery systems

    2015, International Journal of Biological Macromolecules
  • Aging skin and wound healing

    2013, Clinics in Geriatric Medicine
  • Fibroblast Differentiation in Wound Healing and Fibrosis

    2007, International Review of Cytology
    Citation Excerpt :

    The macrophage is a central figure in chronic inflammation because of the great number of biologically active products it can produce (Vangelista et al., 1991). Growth factors the macrophage is known to synthesize and secrete include PDGF (Zhuo et al., 1998), FGF‐2 (Baird et al., 1985), and TGFβ1 (Associan et al., 1987). Compelling evidence for the role of macrophages as mediators of injury has been provided by renal studies in which macrophage infiltration was reduced by X‐ray irradiation (Diamond and Pesek‐Diamond, 1991) and antimacrophage serum (Matsumoto and Hatane, 1989).

View all citing articles on Scopus

Present Address: Biochemisches Institute, University of Zurich Winterthurerstr. 190, CH-8057, Zurich, Switzerland

View full text